AlphaFold predicted structure
DYNC1I2 · Q13409

Mean pLDDT
72.7/ 100
Confident
638 residues
Confidence breakdown
- Very high(≥ 90)17%
- Confident(70–90)52%
- Low(50–70)10%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dynein cytoplasmic 1 intermediate chain 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with microcephaly and structural brain anomalies
neurodegenerative disease
viral infectious disease
lysosomal storage disease
neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies
Parkinson disease
Alzheimer disease
multiple sclerosis
tuberculosis
Pain
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cytoplasmic dynein 1 intermediate chain 2
Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function (PubMed:31079899). Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules (PubMed:31079899). The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150-glued) DCTN1 (By similarity). Involved in membrane-transport, such as Golgi apparatus, late endosomes and lysosomes (By similarity)
DYNC1I2 · Q13409

Mean pLDDT
72.7/ 100
Confident
638 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0